A. Schally, Oncological applications of somatostatin analogues, Cancer Res, vol.48, pp.6977-6895, 1988.

D. G. Bostwick, W. E. Null, D. Holmes, E. Weber, J. D. Barchas et al., Expression of Opioid Peptides in Tumors, New England Journal of Medicine, vol.317, issue.23, pp.1439-1443, 1987.
DOI : 10.1056/NEJM198712033172304

I. S. Zagon, . P. Mclaughlin, . S. Goodman, and R. E. Rhodes, Opioid receptors and endogenous opioids in diverse human and animal cancers, J. Nati Cancer. Inst, vol.79, pp.1059-1065, 1987.

T. Reisine and G. Bell, Molecular biology of somatostatin receptors, Endocr. Rev, vol.16, pp.427-442, 1995.
DOI : 10.1210/er.16.4.427

T. Reisine and G. , Molecular biologyof opioidreceptors, TrendsNeurosci, vol.16, pp.506-510, 1993.

. C. Aylsworth, C. A. Flodson, and J. Meites, Opiate Antagonists Can Inhibit Mammary Tumor Growth in Rats, Experimental Biology and Medicine, vol.161, issue.1, pp.18-20, 1979.
DOI : 10.3181/00379727-161-40479

E. M. Scholar, L. Violi, and T. D. Hexum, The antimetastatic activity of enkephalin-like peptides, Cancer Letters, vol.35, issue.2, pp.133-138, 1987.
DOI : 10.1016/0304-3835(87)90036-X

S. W. Lamberts, E. P. Krenning, and J. , The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors, Endocrine Reviews, vol.12, issue.4, pp.450-482, 1991.
DOI : 10.1210/edrv-12-4-450

A. E. Bogden, . J. Taylor, J. Moreau, D. H. Coy, and D. J. Lepage, Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatu line), Cancer Res, vol.50, pp.4360-4365, 1990.

I. Prevost, G. P. Foehle, E. Thomas, F. Pihan, I. Veber et al., Growth of human beast cancer cells inhibited by the somatostatin analog BIM-230'4C (Somatuline), Endocrinology, vol.128, pp.323-329, 1991.

B. Seytono-han, M. S. Henkelman, J. A. Fockens, and J. G. And-klijn, Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

D. R. Ciocca, L. A. Puy, L. C. Fasoli, . Tello, J. C. Aznar et al., Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients, Breast Cancer Research and Treatment, vol.11, issue.3, pp.175-184, 1990.
DOI : 10.1038/bjc.1957.43

L. Scopsi, E. Balslev, N. Brunner, H. Skovgaart-poulsen, J. Andersen et al., Immunoreactive opioid peptides in human breast cancer, Am. J. Pathol, vol.134, pp.473-479, 1989.

J. C. Reubi, J. C. Schaer, B. Waser, and G. Mengod, Expression and localization of somatostatin receptor SSTRI, SSTR2, and SSTR3 messenger RNA in primary human tumors using in situ hybridization, Cancer Res, vol.54, pp.3455-3459, 1994.

J. C. Reubi, E. Krenning, S. W. Lamberts, and L. Kvols, In vitro detection of somatostatin receptors in human tumors, Metabolism, p.41, 1992.
DOI : 10.1159/000201082

G. Srkalovic, R. Z. Cai, and A. Schally, Evaluation of Receptors for Somatostatin in Various Tumors Using Different Analogs*, The Journal of Clinical Endocrinology & Metabolism, vol.70, issue.3, pp.661-669, 1990.
DOI : 10.1210/jcem-70-3-661

J. A. Foekens, H. Portengen, W. L. Van-putten, . A. Trapman, J. Reubi et al., Prognostic value of receptors for insulin-like growth factor I, somatostatin, and epidermal growth factor in human breast cancer, Cancer Res, vol.49, pp.7002-7009, 1989.

G. Prevost, M. Lanson, F. Thomas, N. Veber, W. Gonzalez et al., Molecular heterogeneity of somatostatin analogueBIM-230'4C receptors in human breast carcinoma cells using the chemical cross-linking assay, Cancer Res, vol.52, pp.843-850, 1992.

G. Weckbecker, R. Liu, L. Tolcsvai, and C. Bruns, Antiproliferative effects of the somatostatin analogue octreotide (SMS 201â? " 995)on ZR-75-l human breast cancer cells in vivo and in vitro, Cancer Res, vol.52, pp.4973-4978, 1992.

A. Hatzoglou, E. Bakogeorgou, C. , and E. , The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors, European Journal of Pharmacology, vol.296, issue.2, 1995.
DOI : 10.1016/0014-2999(95)00703-2

R. Maneckjee, R. Biswas, and B. K. Vonderhaar, Binding of opioids to human MCF-7 breast cancer cells and their effects on growth, Cancer Res, vol.50, pp.2234-2238, 1990.

P. J. Munson, R. , and D. , LIGAND: A versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, vol.107, issue.1, pp.220-239, 1980.
DOI : 10.1016/0003-2697(80)90515-1

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1973.
DOI : 10.1016/0022-1759(83)90303-4

P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Analytical Biochemistry, vol.162, issue.1, pp.156-159, 1987.
DOI : 10.1016/0003-2697(87)90021-2

P. A. Eden, T. , and J. E. , Somatostatin receptor subtype gene expression in human and rodent tumors, Life Sciences, vol.53, issue.1, pp.85-90, 1993.
DOI : 10.1016/0024-3205(93)90614-9

J. C. Reubi, B. Waser, J. A. Foekens, J. G. Klijn, S. W. Lambert et al., Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: Relationship to egf receptors, International Journal of Cancer, vol.183, issue.3, p.420, 1990.
DOI : 10.1016/S0344-0338(88)80154-7

A. H. Bootsma, C. Van-eijk, K. K. Schouten, J. C. Reubi, B. Waser et al., Somatostatin receptor-positive primary breast tumors: Genetic, patient and tumor characteristics, International Journal of Cancer, vol.4, issue.3, pp.357-362, 1993.
DOI : 10.1093/ajcp/78.6.806

L. Buscail, J. P. Esteve, H. Prats, F. Bayard, G. I. Bell et al., Human somatostatin receptor hSSTR2 may mediate the antiproliferative effect of octreotide, Gastroenterology, vol.104, pp.8-14, 1993.

Y. Berthois, M. Pons, C. Dussert, . Cra, A. De-paulet et al., Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site, Molecular and Cellular Endocrinology, vol.99, issue.2, pp.259-268, 1994.
DOI : 10.1016/0303-7207(94)90016-7

X. Dong, Y. Berthois, M. , and P. , Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptors, Anticancer Res, vol.11, pp.737-744, 1991.

R. Maurer, B. H. Gaehwiler, H. H. Buescher, R. C. Hill, and D. Roemer, Opiate antagonistic properties of an octapeptide somatostatin analog., Proc. NatI. Acad. Sci
DOI : 10.1073/pnas.79.15.4815

URL : http://www.pnas.org/content/79/15/4815.full.pdf

J. M. Walker, W. D. Bowen, S. T. Atkins, M. K. Hemstreet, C. et al., ??-Opiate binding and morphine antagonism by octapeptide analogs of somatostatin, Peptides, vol.8, issue.5, pp.869-875, 1987.
DOI : 10.1016/0196-9781(87)90074-X